Vancomycin Reduction Practices (VRP) in the NICU
Key facts
- Who runs it
- Children's Hospital of Philadelphia
- Where
- Lancaster, Modesto, Oakland, Philadelphia, Plainsboro, Roseville, San Francisco, San Leandro, Santa Clara, Voorhees Township, Walnut Creek, and West Chester, United StatesSee the 13 sites
- Trial code
- Status
- Recruiting
- People taking part
- 13 people, planned
- Started
- 2 Jun 2025
- Expected to end
- Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- External Facilitation
- Record updated
- 24 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Level III NICU
- Affiliated with Kaiser Permanente Northern California (KPNC) or Children's Hospital of Philadelphia Newborn Care Network (CNBCN)
- Recruited by study team
Who cannot take part
- Site not recruited for the study
Where in United States
- Lancaster General HospitalLancaster, United StatesContact: Dr. Sagori MukhopadhyayTaking people
- Kaiser Permanente Modesto Medical CenterModesto, United StatesContact: Dr. Michael W. KuzniewiczTaking people
- Kaiser Permanente East Bay - Oakland Medical CenterOakland, United StatesContact: Dr. Michael W. KuzniewiczTaking people
- Hospital of the University of PennsylvaniaPhiladelphia, United StatesContact: Dr. Sagori MukhopdhyayTaking people
- Pennsylvania HospitalPhiladelphia, United StatesContact: Dr. Sagori MukhopadhyayTaking people
- Medical Center of PrincetonPlainsboro, United StatesContact: Dr. Sagori MukhopadhyayTaking people
- Kaiser Permanente Roseville Medical CenterRoseville, United StatesContact: Dr. Michael W. KuzniewiczTaking people
- Kaiser Permanente San Francisco Medical CenterSan Francisco, United StatesContact: Dr. Michael W. KuzniewiczTaking people
- Kaiser Permanente - San Leandro Medical CenterSan Leandro, United StatesContact: Dr. Michael W. KuzniewiczTaking people
- Kaiser Permanente Santa Clara Medical CenterSanta Clara, United StatesContact: Dr. Michael W. KuzniewiczTaking people
- Virtua VoorheesVoorhees Township, United StatesContact: Dr. Sagori MukhopadhyayTaking people
- Kaiser Permanente Walnut Creek Medical CenterWalnut Creek, United StatesContact: Dr. Michael W. KuzniewiczTaking people
- Chester County HospitalWest Chester, United StatesContact: Dr. Sagori MukhopadhyayTaking people
About the trial
What the trial wants to find out
This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.
The 2 groups in the trial
- Sites receiving external facilitationTreatment being tested
Sites will receive guidance from an external facilitator to support uptake of the VRP.
Treatment: External Facilitation
- Sites not receiving external facilitationNo study treatment, for comparison
Sites will not receive guidance from an external facilitator.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Implementing Vancomycin Reducing Practices (VRP) in Preterm Infants
- Record updated
- 24 September 2026